About Momentum Bioscience
Momentum Bioscience is a company based in Cardiff (United Kingdom) founded in 2008.. Momentum Bioscience has raised $5.75 million across 2 funding rounds from investors including IIG PLC. The company has 12 employees as of October 31, 2021. Momentum Bioscience offers products and services including SepsiSTAT System and Rapid Phenotypic AST. Momentum Bioscience operates in a competitive market with competitors including Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter Cardiff, United Kingdom
- Employees 12 as on 31 Oct, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Momentum Bioscience Limited
- Date of Incorporation 17 Oct, 2005
- Jurisdiction CARDIFF, WALES
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.75 M (USD)
in 2 rounds
-
Latest Funding Round
$5.4 M (USD), Series A
Sep 15, 2021
- Investors
-
Employee Count
12
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Momentum Bioscience
Momentum Bioscience offers a comprehensive portfolio of products and services, including SepsiSTAT System and Rapid Phenotypic AST. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables rapid detection and testing of bloodstream infections from blood samples.
Accelerates antibiotic susceptibility results for sepsis treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Momentum Bioscience
Momentum Bioscience has successfully raised a total of $5.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.4 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.4M
-
First Round
First Round
(26 Sep 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series A - Momentum Bioscience | Valuation |
investors |
|
| Sep, 2011 | Amount | Seed - Momentum Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Momentum Bioscience
Momentum Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IIG PLC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by IIG toward life sciences startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Momentum Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Momentum Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Momentum Bioscience Comparisons
Competitors of Momentum Bioscience
Momentum Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Momentum Bioscience
Frequently Asked Questions about Momentum Bioscience
When was Momentum Bioscience founded?
Momentum Bioscience was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Where is Momentum Bioscience located?
Momentum Bioscience is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Is Momentum Bioscience a funded company?
Momentum Bioscience is a funded company, having raised a total of $5.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $355K, raised on Sep 26, 2011.
How many employees does Momentum Bioscience have?
As of Oct 31, 2021, the latest employee count at Momentum Bioscience is 12.
What does Momentum Bioscience do?
Developer of diagnostic solutions for the detection of infectious diseases. Its proprietary platform Enzymatic Template Generation Amplification (ETGA) detects microbial infections by measuring nucleic acid modifying enzymes. The companys flagship product is Cognition is based on ETGA technology.
Who are the top competitors of Momentum Bioscience?
Momentum Bioscience's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Momentum Bioscience offer?
Momentum Bioscience offers SepsiSTAT System and Rapid Phenotypic AST.
Who are Momentum Bioscience's investors?
Momentum Bioscience has 1 investor. Key investors include IIG PLC.